AQP4 and Alzheimer disease: Of note, post-mortem analysis of AD patients show heightened expression of AQP4, suggesting disrupted BBB permeability that may result in reduced amyloid beta clearance and entry of neurotoxic and pro-inflammatory molecules 98-100, which can ultimately lead to changes in metabolic activity and neuronal function.